Press release
Major Force in the Venous Thromboembolism Market 2025: Impact Of Healthcare Infrastructure Expansion On The Venous Thromboembolism Market
Venous Thromboembolism Market Research
Over the past few years, the venous thromboembolism market has experienced a steady increase in its size. It's projected to expand from $2.44 billion in 2024 to $2.55 billion in 2025, rising at a compound annual growth rate (CAGR) of 4.4%. The growth during the historic period can be credited to an increasing elderly population, progress in anticoagulants, favorable reimbursement policies, and an increase in investments.
The market size of venous thromboembolism is predicted to experience consistent growth in the forthcoming years. The market is set to expand to $3.02 billion by 2029, registering a compound annual growth rate (CAGR) of 4.4%. The growth within the projected period can be attributed to factors such as enhanced access to global healthcare, genetic risk evaluation, telemedicine, and remote patient monitoring, in addition to patient education and support. Key trends projected for this period comprise extended thromboprophylaxis, innovative oral anticoagulants, individualized treatment plans, and high-tech diagnostic imaging technologies.
What Key Elements Are Boosting Growth in the Venous Thromboembolism Market?
The rise in healthcare facilities is predicted to fuel the growth of the venous thromboembolism market. The involvement and integration of sectors in the economic system that present products and services for curing, palliative care, rehabilitation and prevention of illnesses define the healthcare industry. The expansion of this industry aids the growth of institutional infrastructure, policies, practices and educational programs essential to support the execution of VTE prevention protocols. For example, as per the American Health Care Association, a nonprofit organization based in the US, the count of hospitals in the US surged to 6,129 from 6,093 in May 2023. Plus, according to the Office for National Statistics in the UK, spending on healthcare in the UK was roughly around £292 billion in 2023 showing a nominal rise of 5.6%. Spending on long-term health and social care also experienced an increase of 2.8% in real terms in 2022. Therefore, the enhancement in healthcare industry fosters the growth of the venous thromboembolism market. Advancement in the Venous Thromboembolism Market is expected due to the rising number of Orthopedic Procedures
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13001&type=smp
Who Are the Major Industry Players Fueling Venous Thromboembolism Market Expansion?
Major companies operating in the venous thromboembolism market are Pfizer Inc., Johnson and Johnson Limited, Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., Bristol-Myers Squibb Company, GlaxoSmithKline plc., Eli Lilly and Co Ltd., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Limited, Otsuka Pharmaceutical Co. Ltd., Menarini Group, Ipsen S.A., Dr. Reddy's Laboratories Ltd., Apotex Inc., Hikma Pharmaceuticals PLC, Cipla Inc., Endo International PLC, Aspen Pharmacare Holdings Limited, Zydus Lifesciences Ltd., LEO Pharma A/S, Lupin Limited, Torrent Pharmaceuticals Ltd., Almirall S.A., Glenmark Pharmaceuticals Ltd., Portola Pharmaceuticals Inc.
Which Key Developments Are Influencing the Venous Thromboembolism Market?
Leading companies within the venous thromboembolism market are focusing on the creation of innovative anticoagulant medications to maintain their strong market foothold. The progression of anticoagulant technology could result in increased efficacy in venous thromboembolism prevention or treatment. For example, Anthos Therapeutics, a clinical-stage biopharmaceutical firm based in the U.S., obtained regulatory approval in September 2022 for its abelacimab anticoagulant medication from the US Food and Drug Administration (FDA). This new treatment is a fully human monoclonal antibody, specifically designed to prevent stroke and systemic embolism in patients suffering from atrial fibrillation. The innovative, once-monthly, dual-acting antibody abelacimab aims to induce hemostasis-sparing anticoagulation by obstructing Factor XI.
How Is the Segmentation of the Venous Thromboembolism Market Defined?
The venous thromboembolism market covered in this report is segmented -
1) By Type: Deep Vein Thrombosis, Pulmonary Embolism, Other Types
2) By Treatment: Anti-Clotting Medications, Mechanical Devices, Thrombolytic Therapy, Other Treatment
3) By End Users: Hospitals, Homecare, Specialty Centers, Other End Users
Subsegments:
1) By Deep Vein Thrombosis (DVT): Proximal DVT, Distal DVT, Asymptomatic DVT
2) By Pulmonary Embolism (PE): Acute PE, Chronic PE, Submassive PE
3) By Other Types: Thrombophlebitis, Superficial Vein Thrombosis, Post-Thrombotic Syndrome
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/venous-thromboembolism-global-market-report
What Is the Leading Region in the Venous Thromboembolism Market?
North America was the largest region in the venous thromboembolism market in 2024. The regions covered in venous thromboembolism market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Is Covered In The Venous Thromboembolism Global Market Report?
- Market Size Analysis: Analyze the Venous Thromboembolism Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Venous Thromboembolism Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Venous Thromboembolism Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Venous Thromboembolism Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13001
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Major Force in the Venous Thromboembolism Market 2025: Impact Of Healthcare Infrastructure Expansion On The Venous Thromboembolism Market here
News-ID: 3856033 • Views: …
More Releases from The Business Research Company
Dispersant Polymer Market to Reach USD $17.92 Billion by 2030 at 12.2% CAGR
The dispersant polymer market is set to experience significant expansion over the coming years, driven by evolving industrial demands and technological advancements. This sector is rapidly adapting to changing consumer preferences and regulatory pressures, positioning itself for robust growth through 2030.
Projected Market Size and Growth Rate for the Dispersant Polymer Market
The dispersant polymer market is anticipated to reach a value of $17.92 billion by 2030, growing at an…
Dipropylene Glycol Monomethyl Ether Market to Reach $2.18 Billion by 2030 with 7 …
The dipropylene glycol monomethyl ether market is poised for significant expansion in the coming years, driven by various industrial and environmental factors. As demand rises across several sectors, the market is set to evolve with new trends and innovations that cater to sustainability and enhanced performance. Below is a detailed overview of the market valuation, key players, emerging trends, and segment classifications to provide a comprehensive understanding of this growing…
Comprehensive Dimethyl Carbonate Market Report Covers Forecasts, Innovations And …
The dimethyl carbonate market is set for notable expansion in the coming years, driven by its versatile use across various industries. As demand surges in key areas like battery manufacturing and sustainable chemical processes, the market's growth trajectory appears promising. Let's explore the current market valuation, leading companies, emerging trends, and segment dynamics shaping this sector.
Dimethyl Carbonate Market Size and Growth Outlook Through 2030
The dimethyl carbonate market is…
Diamond Coatings Market Revenue To Cross $4.59 Billion By 2030 Supported By Risi …
The diamond coatings market is set for significant expansion over the coming years, driven by technological advancements and increasing applications across various industries. As demand grows for high-performance materials and coatings, this sector is positioned to experience robust development through 2030 and beyond. Let's explore the market's projected value, key players, emerging trends, and the segments shaping its future.
Diamond Coatings Market Size and Projected Growth Through 2030
The diamond…
More Releases for Venous
Key Trends Reshaping the Chronic Venous Occlusions Treatment Market: Introductio …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Chronic Venous Occlusions Treatment Market Size Growth Forecast: What to Expect by 2025?
The market dedicated to therapies for chronic venous occlusions has experienced robust expansion lately, projected to increase from a valuation of $6.7 billion in 2024 to $7.15 billion the following year, reflecting a consistent compound annual…
States Venous Stents Market Projected to Witness Expansion with Rising Incidence …
States Venous Stents Market Overview
The States Venous Stents Market is expected to grow from USD 1.3 billion in 2025 to USD 2.4 billion by 2032, registering a CAGR of 8.9%.
Coherent Market Insights is pleased to release its latest States Venous Stents Market research report, offering an in-depth analysis of the U.S. States Venous Stents Market Landscape from 2025 to 2032. This report delivers reliable projections across national and regional levels,…
Venous Stent Market Grows with Rising Cases of Chronic Venous Disorders | Boston …
Venous Stent Market Overview
The venous stent market is anticipated to grow from USD 0.6 billion in 2025 to USD 1.3 billion by 2032, exhibiting a CAGR of 10.3% during the forecast period.
Coherent Market Insights is proud to announce the release of its latest market research report, providing a comprehensive analysis of the Venous Stent Market Landscape from 2025 to 2032. This report delivers precise forecasts across global, regional, and country…
Venous Skin Ulcer Treatment Market : Lucrative Opportunities
Venous Skin Ulcer Treatment Market: Introduction
According to the report, the global venous skin ulcer treatment market was valued at US$ 2.6 Bn in 2019. It is expected to expand at a CAGR of ~5% during the forecast period from 2020 to 2030. Various advanced technologies and treatment options are presently available for venous skin ulcer. The treatment for skin ulcer include different therapies such as compression therapy, advanced wound dressings,…
Increasing Prevalence of Venous Thromboembolism to Augment Growth of the Venous …
Venous thromboembolism (VTE) is the formation of blood clots in the bloodstream. Two main types of venous thromboembolism are pulmonary embolism and deep vein thrombosis. The formation of blood clots in a deep vein is called deep vein thrombosis, while the deep vein thrombosis formed breaks the clot and travels to the lungs, known as pulmonary embolism.
Sample Copy Of Report @ https://www.coherentmarketinsights.com/insight/request-sample/188
Pulmonary embolism occurs in almost one-third of patients…
Venous Thromboembolism Treatment Market Analysis by 2028
Global Venous Thromboembolism Treatment Market: Overview
When a blood clot is stuck in a vein is known as venous thromboembolism (VTE), this block the flow of blood to the other parts. A person facing this situation requires immediate medical attention. According to various studies, venous thromboembolism is considered as a third leading cause for vascular diagnosis after heart attack and stroke. There are about 300,000 to 600,000 individuals facing…
